{"id":17948,"date":"2014-05-02T04:30:00","date_gmt":"2014-05-02T02:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/bayer-vuole-i-farmaci-a-largo-consumo-di-merck-2\/"},"modified":"2014-05-02T04:30:00","modified_gmt":"2014-05-02T02:30:00","slug":"bayer-vuole-i-farmaci-a-largo-consumo-di-merck-2","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/bayer-vuole-i-farmaci-a-largo-consumo-di-merck-2\/","title":{"rendered":"Bayer wants Merck&#039;s consumer drugs"},"content":{"rendered":"<p class=\"MsoNormal\" style=\"text-align: left; line-height: 13.5pt; margin: 0cm 0cm 6pt; background: white\"><span style=\"font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT\"><font size=\"3\">&nbsp;<img decoding=\"async\" class=\"rg_i\" name=\"aWD2PTnRgHgn9M:\" src=\"https:\/\/encrypted-tbn2.gstatic.com\/images?q=tbn:ANd9GcTHpN6JtJed098kFvcoyjFp5wq_RYbWHpt9MRSJqRrUsAf6oDVycQ\" data-sz=\"f\" data-src=\"https:\/\/encrypted-tbn2.gstatic.com\/images?q=tbn:ANd9GcTHpN6JtJed098kFvcoyjFp5wq_RYbWHpt9MRSJqRrUsAf6oDVycQ\" style=\"margin-top: 0px; width: 256px; height: 197px; margin-left: 0px; margin-right: 0px\" alt=\"\" \/><\/font><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: 13.5pt; margin: 0cm 0cm 6pt; background: white\"><span style=\"font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT\"><font size=\"3\">BERLIN \u2013 The <b>German pharmaceutical company Bayer<\/b> entered into exclusive negotiations to purchase Merck&#039;s consumer drug division.<\/p>\n<p><\/font><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: 13.5pt; margin: 0cm 0cm 6pt; background: white\"><span style=\"font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT\"><font size=\"3\">The offer, according to reports from sources close to the negotiations between the companies, would amount to about 14 billion dollars, to be paid partly in cash and partly with an exchange of pharmaceutical assets, with the probably formation of a common joint venture. Bayer remained the only one in contention after the withdrawal of the British Reckitt Benckiser.<\/p>\n<p><\/font><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: normal; margin: 0cm 0cm 10pt; background: white\"><span style=\"font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: black; font-size: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT; mso-bidi-font-weight: bold\">2.05.2014 \u2013 <\/span><b><i style=\"mso-bidi-font-style: normal\"><span style=\"font-family: &quot;Bodoni MT&quot;,&quot;serif&quot;; color: black; font-size: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT; mso-bidi-font-family: Arial\">TICINO COURIER<\/p>\n<p><\/span><\/i><\/b><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: normal; margin: 0cm 0cm 10pt; background: white\"><span style=\"font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: #c00000; font-size: 18pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT; mso-bidi-font-weight: bold\">AstraZeneca, Pfizer raise offer to 50 pounds, but British company says no<\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: normal; margin: 0cm 0cm 10pt; background: white\"><span style=\"font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: black; font-size: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT; mso-bidi-font-weight: bold\">Friday 2nd May 2014<span style=\"mso-spacerun: yes\">&nbsp; <\/span>Reuters<\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 6pt\"><span style=\"font-family: &quot;Arial&quot;,&quot;sans-serif&quot;\"><font size=\"3\">LONDON, May 2 (Reuters) - AstraZeneca also rejected a new takeover offer by US drugmaker Pfizer, which raised its offer to \u00a350 ($84.47) per share. The board of the British company said no to the improvement proposal which values the group at 106 billion dollars, or 63 billion pounds, stressing that the offer does not fully value the group.<\/p>\n<p><\/font><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 6pt\"><span style=\"font-family: &quot;Arial&quot;,&quot;sans-serif&quot;\"><font size=\"3\">&quot;Pfizer&#039;s proposal will dilute dramatically<\/p>","protected":false},"excerpt":{"rendered":"<p>&nbsp; BERLINO &#8211; La casa farmaceutica tedesca Bayer ha avviato trattative in esclusiva per l&#8217;acquisto della divisione farmaci di largo consumo della Merck. L&#8217;offerta, secondo quanto riferito da fonti vicine al negoziato tra le societ&agrave;, ammonterebbe a circa 14 miliardi di dollari, da pagare in parte in contanti e in parte con uno scambio di &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-17948","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/17948","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=17948"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/17948\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=17948"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=17948"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=17948"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}